FAQ — Packaging¶

Field	Value
Document ID	RPL-FAQ-PKG-001
Version	1.0
Publisher	RPL Peptide (Qingdao RPL Biotechnology Co., Ltd.)
URL	https://rplpeptides.com
Last Updated	July 2026

1. Vial Types and Materials¶

Q1: What type of glass is used for peptide vials, and why does it matter?¶

A: Most peptide vials are made from Type I borosilicate glass, which contains approximately 10–13% boron trioxide (B₂O₃). This formulation gives the glass a low coefficient of thermal expansion, high chemical resistance, and low leachability. Type I glass is the industry standard for pharmaceutical packaging because it resists cracking during freeze-thaw cycles, does not release significant alkali ions into the contents, and withstands the extreme temperature gradients of lyophilization. Lower-grade soda-lime glass is unsuitable for peptide storage.

Q2: What are the differences between clear and amber vials?¶

A: Clear vials allow visual inspection of the lyophilized cake or reconstituted solution but provide no protection against light-induced degradation. Amber vials contain iron oxide or other additives that block UV and visible light below approximately 500 nm, protecting light-sensitive peptides (those containing tryptophan, tyrosine, or methionine) from photo-oxidation. The trade-off is that amber glass has slightly higher leachable levels due to the metal oxide additives. For most routine storage, amber vials are preferred; clear vials are acceptable if stored in light-protected containers.

Q3: What materials are used for the rubber stoppers in peptide vials?¶

A: Rubber stoppers are typically made from chlorobutyl or bromobutyl rubber — synthetic elastomers chosen for low gas permeability, chemical inertness, and minimal extractable content. These formulations provide an excellent seal against moisture and oxygen ingress. Some stoppers are coated with a fluoropolymer film (e.g., ETFE or PTFE) on the product-contact side to further reduce extractables and minimize peptide adsorption to the rubber surface. The stopper material must be tested for biocompatibility and should not leach substances that interfere with HPLC or mass spectrometry analysis.

Q4: What is a flip-off seal, and what purpose does it serve?¶

A: A flip-off seal (also called a flip-cap or tear-off seal) is a plastic or aluminum cap that covers the rubber stopper of a vial. Its primary purpose is tamper-evidence — the seal must be removed or broken before the stopper can be accessed. The center portion typically flips open to expose the injection port of the stopper, allowing needle access without removing the entire seal. The seal also helps maintain the sterility of the stopper surface during storage. RPL Peptide uses color-coded flip-off seals to aid in product identification.

Q5: How are vials cleaned and prepared before filling?¶

A: Pharmaceutical-grade vials undergo a multi-step preparation process. First, they are washed with purified water and often treated with a depyrogenation tunnel (dry heat at 300°C+) to destroy any endotoxins remaining from the manufacturing process. For sterile products, the empty vials are sterilized and the filling is performed under Grade A (ISO 5) laminar flow conditions. The stoppers are washed, siliconized (a thin silicone coating to aid insertion), and sterilized separately before being seated onto the filled vials. The entire process is validated to ensure bioburden and endotoxin levels remain within specification.

Q6: What is the typical fill volume and headspace in a peptide vial?¶

A: Fill volumes are designed to leave appropriate headspace for lyophilization and to accommodate the required reconstitution volume. Typical vial sizes range from 2 mL to 20 mL for standard peptide products. The headspace (the air above the lyophilized cake) is often purged with nitrogen or argon before stoppering to displace oxygen and reduce oxidation risk. Inert gas blanketing is especially important for peptides containing methionine, cysteine, or tryptophan residues, which are prone to oxidative degradation.

2. Labeling and Secondary Packaging¶

Q7: What information is included on a peptide vial label?¶

A: A compliant peptide vial label includes: product name, peptide sequence or identifier, batch/lot number, declared content (e.g., 5 mg per vial), purity grade, storage condition (e.g., "Store at -20°C"), manufacturing date, expiry date or retest date, manufacturer name (RPL Peptide), and relevant hazard warnings (e.g., "For research use only"). Some labels also include a 2D barcode for automated tracking. The label material must withstand cold storage conditions without delaminating — typically a cryogenic-rated adhesive label is used.

Q8: What role do desiccants play in peptide packaging?¶

A: Desiccants such as silica gel or molecular sieves are included in the secondary packaging (outer container or bag) to maintain low humidity around the vial. Lyophilized peptides are hygroscopic — they readily absorb moisture from the air, which can accelerate hydrolysis, aggregation, and microbial growth. By keeping the relative humidity below 30% inside the sealed package, desiccants extend the shelf life of the product. Some desiccants include color-change indicators (e.g., blue-to-pink silica gel) that signal when they have become saturated and need replacement.

Q9: How is temperature-controlled shipping arranged for peptide products?¶

A: RPL Peptide ships temperature-sensitive products using insulated packaging (EPS foam or vacuum-insulated panels), temperature-stabilizing gel packs or dry ice, and temperature data loggers inside the package. The packaging system is designed to maintain the required temperature (−20°C, 2–8°C, or dry ice level) for at least 48–72 hours under normal transit conditions. Shipments are clearly labeled with handling instructions such as "Keep Frozen" or "Refrigerate Upon Arrival." The temperature logger record is available upon request to confirm proper cold chain maintenance.

Q10: What quality checks are performed on packaging materials before use?¶

A: Incoming packaging materials (vials, stoppers, seals, labels, secondary packaging) are inspected against defined specifications. Vials are checked for dimensional consistency, visual defects (cracks, chips, scratches), and chemical resistance. Stoppers are tested for dimensional fit, integrity, and extractable/leachable profiles. Labels are verified for adhesion under storage conditions, print legibility, and barcode readability. Any lot that fails incoming inspection is quarantined and returned to the supplier. Only approved packaging lots are used in production.

Q11: What is the purpose of tamper-evident packaging for peptides?¶

A: Tamper-evident packaging provides visible evidence that a product has been opened or interfered with before receipt. For peptide vials, the primary tamper-evident feature is the flip-off seal — if the seal is broken or missing upon arrival, the product should not be used. Secondary packaging may include shrink bands or security tape on the outer box. These measures protect both the supplier and the end user by ensuring product integrity throughout the supply chain.

Q12: How should peptide vials be stored in their secondary packaging?¶

A: Peptide vials should remain in their secondary packaging until immediate use. The outer packaging (box or bag) provides additional protection against light, moisture, and physical damage. If storage space is limited, vials may be removed from the outer box and placed in a labeled storage container, but they should always be shielded from light and moisture. Frequently accessed vials can be stored in a desiccated container at the recommended temperature. Never store vials directly on freezer shelving without some form of secondary containment.

Document Revision History¶

Version	Date	Changes
1.0	July 2026	Initial release

rplpeptides.com